Invesco Ltd. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$7,764,000
+22082.9%
1,501,699
+10979.4%
0.00%
Q1 2021$35,000
+29.6%
13,554
+24.3%
0.00%
Q4 2020$27,000
-94.7%
10,905
-92.7%
0.00%
Q3 2019$513,000
+1408.8%
150,364
+1071.9%
0.00%
Q4 2018$34,000
-52.1%
12,831
+0.8%
0.00%
Q3 2018$71,000
-64.3%
12,732
-67.7%
0.00%
Q2 2018$199,000
-75.5%
39,392
-66.9%
0.00%
Q1 2018$812,000119,0520.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 5,628,585$5,853,7285.06%
Aquilo Capital Management, LLC 4,552,876$4,734,9911.78%
BVF INC/IL 5,080,320$5,283,5330.22%
Soleus Capital Management, L.P. 1,000,000$1,040,0000.15%
Cutter & CO Brokerage, Inc. 378,479$393,6180.13%
PLATINUM INVESTMENT MANAGEMENT LTD 1,220,798$1,269,6300.05%
GSA CAPITAL PARTNERS LLP 365,047$3800.05%
Annandale Capital, LLC 67,000$700.02%
WEALTH EFFECTS LLC 21,700$22,5680.01%
Sigma Planning Corp 343,934$357,6910.01%
View complete list of PIERIS PHARMACEUTICALS INC shareholders